The Global Longevity and Anti-Senescence Therapy Market Size is anticipated to exceed USD 45.24 billion by 2033, growing at a CAGR of 6.07% from 2023 to 2033. The rise of the longevity and anti-senescence therapy industries is anticipated to benefit greatly from the rising need for cell-based assays in R&D.